Navigation Links
Researchers develop novel polymer to help oral medications reach the bloodstream
Date:8/28/2013

nt drugs more bioavailable through the creation of polymers tailor-made for this purpose."

Many important drugs are like table salt; they crystallize easily. When they do, the crystals are stubbornly difficult to dissolve. They crystallize instead of remaining dispersed, whether in the pill or after release in the digestive tract. Many medicines locked into crystals don't dissolve fast enough to work properly. If that happens, they can't reach their target.

Polymers are introduced to interfere with crystallization. "But the polymers that are presently FDA approved are not effective in meeting all the challenges," said Edgar. "They may prevent a process called nucleation but not stop growth of the crystal if it gets started. Or they may not continue to work after a period of time or if conditions are too hot or too damp. We needed to design a better polymer."

Imagine sugar dissolved in water. If a bit of dust is introduced, it can lead to nucleation the sugar sticks to the dust and then crystal growth. In this example, the polymer would cover the dust mote and repel the sugar molecules, preventing nucleation.

"Stopping nucleation is relatively easy, like stopping a skier before he starts down the hill," said Edgar. "Stopping growth is harder, like trying to stop the skier once he is speeding down the slope. But our polymers can do both stop nucleation and growth."

Edgar and Taylor are working with natural cellulose to create derivatives known as cellulose esters. "They are the polymers used to create LCD screens, automotive paint, and cellophane tape," said Edgar. "Cellulose is an abundant, renewable, completely natural polymer used by nature as the 'steel reinforcing rod' of trees and a major component of all plants."

The Virginia Tech and Purdue groups have discovered that the effective design for pharmaceutical applications is cellulose omega-carboxyesters, which are cellulose esters that the researchers hav
'/>"/>

Contact: Lynn Davis
davisl@vt.edu
540-231-6157
Virginia Tech
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Researchers develop rapid, cost-effective early detection method for organ transplant injury
2. UTHealth, Swedish researchers uncover mystery in blot clotting disorder
3. Researchers develop software tool for cancer genomics
4. Rice, MD Anderson researchers win NIH grant to study protein networks
5. Researchers discover how inhibitory neurons behave during critical periods of learning
6. UCLA researchers invent portable device for common kidney tests
7. Harvard Stem Cell researchers create cells that line blood vessels
8. Researchers figure out why gold nanoparticles can penetrate cell walls
9. Finnish researchers develop quick test kit for detecting phenolic compounds in drinking water
10. BIDMC cardiovascular institute researchers will lead $4 million NIH grant to study micrornas
11. UC Davis researchers discover molecular target for the bacterial infection brucellosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... The 10 th International Conference on Genomics (ICG-10, ... in Shenzhen , China ... anniversary this year. Since its inauguration in 2006, ICG ... in the ,omics, fields, and is one of the most ... focuses on recent breakthroughs and advances in ,omics, research that ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/27/2015)... JOSE, Calif. , July 27, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... ® touchscreen solution for its stylish smartwatch. ... for its proven reliability, low power and highly ... a wet finger. Huawei designers also required a ...
Breaking Biology News(10 mins):The 10th International Conference on Genomics (ICG-10) to Open in October 2CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... from “vile and cynical exploitation?by the alternative medicines industry, argues ... estimated that up to 80% of all patients with cancer ... help treat their cancer, writes Jonathan Waxman, Professor of Oncology ... the use of many of these approaches is obtuse ?one ...
... chemotherapy with short-term structural changes in cognitive areas ... Published in the January 1, 2007 issue of ... the American Cancer Society, the study reveals that ... regions of the brain associated with memory, analysis ...
... by other patients whose treatment has to be dropped to ... New guidance from the National Institute for health and Clinical ... it provides no extra funding and does not suggest what ... leaves medical staff with difficult decisions to make. , ...
Cached Biology News:Protect patients from exploitation by alternative medicines industry 2Chemotherapy temporarily affects the structures of the human brain 2Other patients bear the real cost of Herceptin 2
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that it ... Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is an ... and how agriculture impacts their daily lives. This unique exhibit also features a birthing ...
(Date:7/30/2015)... 2015 According to a new ... Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract ... Trial), by End Users - Global Forecast to 2020", ... reach USD 2,107.99 million by 2020 from USD 1,034.93 ... Browse more than 75 ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, ... has been granted,U.S. Patent 7,264,798 entitled "Sensitization ... Virus." The claims describe a method of,using ... drug,resistance to chemotherapeutic agents. "Recent research ...
... Hyatt New York on Monday, September 10th, ... a biopharmaceutical company developing patient-specific, active,immunotherapies for the ... Ph.D., President and Chief Executive Officer, will present ... 1:30 p.m. Eastern,time on Monday, September 10, 2007. ...
... in ... Hong Kong, China, SAN ... leading China biometrics company Miaxis,Biometrics Co., Ltd has been officially selected ... The news has been,announced at a gala dinner during the ,Red ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent 2Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 2Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 3
... Assay with FAM-Labeled Substrate (green fluorescence; ... measure serine protease activation • No ... FLISP Kits utilize cell-permeable, fluorescently labeled ... measure chymotrypsin-like activity in whole living ...
... Engine instrument is the cycler that ... thermal uniformity and swappable blocks ensure ... This rugged machine is more ... platform for new features and upgrades ...
... The Easy Cap tool provides ... seat domed double-locking caps in tubes ... has a wide end that firmly ... prevent accidental crushing when opening or ...
... Multiple Species Tissue Array (MSTA) slides were designed ... and tissues from multiple species. Tissue slices ... MSTA slide which can then be treated as ... or in situ hybridization. This ...
Biology Products: